Instytut Biologii Medycznej PAN

Main page



Pharmaceuticals – special issue: Epigenetic Drugs.


Cells - special issue: The Metabolism of Nucleic Acids, Cell Division, Cholesterol Degradation, Cell Wall Biosynthesis and Host-Pathogen Interactions in Tuberculosis.


The Institute of Medical Biology, together with 32 other European institutions operating within the structure of EU-OPENSCREEN ERIC consortium, participated in H2020-INFRADEV-2018- competition, and received a subsidy for the project EU-OPENSCREEN-DRIVE. The project aims to support undertakings concerning the research infrastructure, also its best use at present and in the future, in which members of the EU-OPENSCREEN ERIC consortium are now involved. Funds provided to the entire project amount to approximately 5 million EUR. The project is launched for 4 years beginning from 1 February 2019.



39 million for three Polish institutions – members of POL-OPENSCREEN Consortium participating in a joint international undertaking called "European Infrastructure of Open Screening Platforms for Chemical Biology European Research Infrastructure Consortium (EU-OPENSCREEN ERIC).

We are more than happy to inform that following the evaluation carried out by a team of international experts three Polish institutions, members of POL-OPENSCREEN consortium, i.e. Institute of Medical Biology PAN, Institute of Biochemistry and Biophysics PAN and Institute of Bioorganic Chemistry PAN, acquired a status of "partner sites" to the EU-OPENSCREEN ERIC European Consortium. On 24 October 2018 IBM PAN, a coordinator of the consortium, received the decision from Ministry of Science and Higher Education regarding the application filed in the name of POL-OPENSCREN consortium to finance the participation of three distinguished institutions in the European consortium.


The funds obtained will be used to create the National Library of Chemical Compounds at IMB PAN, and to modernize and increase the capacity of screening studies aimed at seeking new biologically active compounds and potential medicines.


Main page